Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

IPSC

Century Therapeutics Inc

Dec 20 • 04:00PM ET

1.10

Dollar change +0.05
Percentage change 4.76	%

Healthcare • Biotechnology • USA • NASD

Peers: CRSP EDIT NTLA BEAM DNLI ARCT SGMO VERV CARR ZNTL

| Held by: VTI IWM VXF IWN VTWO SCHA IWC VHT SCHB VTWV

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.86	Insider Own	59.06%	Shs Outstand	84.76M	Perf Week	-9.84%
Market Cap	97.98M	Forward P/E	-	EPS next Y	-1.76	Insider Trans	-0.01%	Shs Float	34.81M	Perf Month	-12.70%
Income	-129.89M	PEG	-	EPS next Q	-0.41	Inst Own	31.01%	Short Float	8.24%	Perf Quarter	-29.03%
Sales	2.69M	P/S	36.43	EPS this Y	30.64%	Inst Trans	26.43%	Short Ratio	5.34	Perf Half Y	-58.96%
Book/sh	2.31	P/B	0.48	EPS next Y	-10.55%	ROA	-33.04%	Short Interest	2.87M	Perf Year	-52.59%
Cash/sh	2.22	P/C	0.49	EPS next 5Y	-	ROE	-62.61%	52W Range	0.98 - 5.51	Perf YTD	-66.87%
Dividend Est.	-	P/FCF	-	EPS past 5Y	15.24%	ROI	-52.69%	52W High	-80.04%	Beta	1.77
Dividend TTM	-	Quick Ratio	10.39	Sales past 5Y	-14.25%	Gross Margin	-404.17%	52W Low	12.24%	ATR (14)	0.13
Dividend Ex-Date	-	Current Ratio	10.39	EPS Y/Y TTM	15.15%	Oper. Margin	-4937.84%	RSI (14)	36.74	Volatility	9.90% 10.94%
Employees	165	Debt/Eq	0.28	Sales Y/Y TTM	7.92%	Profit Margin	-4837.73%	Recom	1.25	Target Price	8.71
Option/Short	Yes / Yes	LT Debt/Eq	0.26	EPS Q/Q	33.03%	Payout	-	Rel Volume	1.90	Prev Close	1.05
Sales Surprise	79.77%	EPS Surprise	17.91%	Sales Q/Q	434.46%	Earnings	Nov 05 BMO	Avg Volume	537.40K	Price	1.10
SMA20	-18.71%	SMA50	-20.16%	SMA200	-53.70%	Trades		Volume	1,021,285	Change	4.76%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-08-24	Initiated	Rodman & Renshaw	Buy	$6
Aug-28-23	Downgrade	JP Morgan	Overweight → Neutral	$28 → $5
Dec-27-22	Initiated	Chardan Capital Markets	Buy	$19
Oct-31-22	Initiated	Guggenheim	Buy	$15
Oct-10-22	Initiated	Canaccord Genuity	Buy	$28
May-23-22	Initiated	H.C. Wainwright	Buy	$27
May-12-22	Initiated	William Blair	Mkt Perform
Jul-13-21	Initiated	Piper Sandler	Overweight	$38
Jul-13-21	Initiated	JP Morgan	Overweight	$40
Jul-13-21	Initiated	BofA Securities	Buy	$34

Nov-26-24 07:00AM	Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire)
Nov-08-24 12:00PM	What Makes Century Therapeutics (IPSC) a New Buy Stock (Zacks)
Nov-05-24 10:15AM	Century Therapeutics, Inc. (IPSC) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +5.56%
09:05AM	Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire)
09:00AM	Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting (GlobeNewswire)
07:00AM	Loading…
Nov-04-24 07:00AM	Century Therapeutics to Present at Guggenheim's Inaugural Healthcare Innovation Conference (GlobeNewswire)
Sep-26-24 07:00AM	Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer (GlobeNewswire)
Aug-08-24 08:50AM	Century Therapeutics, Inc. (IPSC) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Jul-09-24 12:00PM	Century Therapeutics (IPSC) Moves to Buy: Rationale Behind the Upgrade (Zacks)
Jun-03-24 07:00AM	Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting (GlobeNewswire)
May-10-24 03:35PM	Century Therapeutics Inc (IPSC) Q1 2024 Earnings: Aligns with EPS Projections Amid Strategic ... (GuruFocus.com)
07:00AM	Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting (GlobeNewswire)
May-09-24 01:54PM	IPSC Stock Earnings: Century Therapeutics Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
08:40AM	Century Therapeutics, Inc. (IPSC) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Loading…
07:30AM	Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Apr-23-24 07:00AM	Century Therapeutics to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit (GlobeNewswire)
Apr-11-24 08:25AM	Century buys a startup, raises funding in cell therapy expansion (BioPharma Dive) +7.14%
07:00AM	Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics (GlobeNewswire)
Apr-08-24 04:05PM	Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting (GlobeNewswire) +6.08%
Mar-25-24 07:00AM	Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors (GlobeNewswire) -9.48%
Mar-19-24 07:00AM	Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference (GlobeNewswire)
Mar-14-24 01:52PM	IPSC Stock Earnings: Century Therapeutics Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace) -7.20%
07:30AM	Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates (GlobeNewswire)
Mar-08-24 11:55PM	Century Therapeutics Inc (IPSC) COO Adrienne Farid Sells 53,515 Shares (GuruFocus.com)
Mar-07-24 09:55AM	How Much Upside is Left in Century Therapeutics, Inc. (IPSC)? Wall Street Analysts Think 193.4% (Zacks) +6.30%
Mar-05-24 06:03PM	Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting (GlobeNewswire) +17.65%
Feb-01-24 07:00AM	Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference (GlobeNewswire)
Dec-09-23 12:00PM	Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion Edits (GlobeNewswire)
Dec-07-23 11:01AM	Century (IPSC) Up 36% on FDA Nod to Begin Phase I Lupus Study (Zacks) +8.37%
07:30AM	Loading…
Dec-06-23 07:30AM	Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus Erythematosus (GlobeNewswire) +36.08%
07:30AM	Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus (GlobeNewswire)
Dec-05-23 08:55AM	Penny Stock Jackpots: 3 High-Stakes Picks With 10-Bagger Potential (InvestorPlace)
Nov-21-23 07:00AM	Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire)
Nov-14-23 03:58PM	FMR LLC Adjusts Position in Century Therapeutics Inc (GuruFocus.com)
Nov-09-23 08:29AM	Century Therapeutics Inc (IPSC) Reports Q3 2023 Financial Results (GuruFocus.com) -13.13%
07:01AM	Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire)
07:00AM	Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer (GlobeNewswire)
07:00AM	Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in Autoimmune and Inflammatory Diseases (GlobeNewswire)
Nov-02-23 09:00AM	Century Therapeutics to Present Initial Clinical Data Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion Edits at the 65th ASH Annual Meeting and Exposition (GlobeNewswire)
Sep-26-23 07:00AM	Century Therapeutics to Present at the Chardan 7th Annual Genetic Medicines Conference (GlobeNewswire)
Aug-09-23 08:50AM	Century Therapeutics, Inc. (IPSC) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:30AM	Century Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire)
Aug-01-23 06:48AM	Century Therapeutics (NASDAQ:IPSC) shareholders have endured a 71% loss from investing in the stock a year ago (Simply Wall St.)
May-12-23 06:11AM	Century Therapeutics First Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
May-11-23 08:55AM	Century Therapeutics, Inc. (IPSC) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
07:30AM	Century Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire)
Apr-17-23 07:00AM	Century Therapeutics to Present at Chardans 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual Summit (GlobeNewswire)
Apr-12-23 08:30AM	Century Therapeutics Announces Leadership Changes (GlobeNewswire) -7.91%
Mar-16-23 08:55AM	Century Therapeutics, Inc. (IPSC) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
07:30AM	Century Therapeutics Reports Full Year 2022 Financial Results and Provides Business Updates (GlobeNewswire)
Mar-15-23 04:01PM	Century Therapeutics to Present at the AACR Annual Meeting 2023 (GlobeNewswire)
Feb-21-23 07:00AM	Century Therapeutics to Present at Upcoming Investor Conferences (GlobeNewswire)
Feb-08-23 07:30AM	Century Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 ELiPSE-1 Trial Evaluating CNTY-101 in Relapsed or Refractory CD19 Positive B-cell Lymphomas (GlobeNewswire)
Feb-01-23 07:00AM	Century Therapeutics to Present at Upcoming Investor Conferences (GlobeNewswire)
Jan-17-23 09:35AM	After Plunging -29.84% in 4 Weeks, Here's Why the Trend Might Reverse for Century Therapeutics, Inc. (IPSC) (Zacks) -7.36%
Jan-09-23 10:46AM	Century Therapeutics becomes latest life sciences company to enact layoffs, narrow focus (American City Business Journals)
Jan-06-23 08:23AM	Century Therapeutics Announces Internal Portfolio Prioritization, Analyst Views It As Incrementally Positive (Benzinga)
Jan-05-23 04:01PM	Century Therapeutics Announces Internal Portfolio Prioritization to Extend Cash Runway Into 2026 (GlobeNewswire)
Jan-04-23 07:00AM	Century Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-08-22 10:02AM	Further weakness as Century Therapeutics (NASDAQ:IPSC) drops 12% this week, taking one-year losses to 39% (Simply Wall St.)
Nov-22-22 07:00AM	Century Therapeutics to Present at the Piper Sandler 34th Annual Healthcare Conference (GlobeNewswire) +5.24%
Nov-11-22 07:00AM	Century Therapeutics Announces Presentation of Preclinical Data at the SITC 37th Annual Meeting and Provides Pipeline Updates (GlobeNewswire) -5.01%
Nov-10-22 08:45AM	Century Therapeutics, Inc. (IPSC) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +15.11%
07:30AM	Century Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates (GlobeNewswire)
Nov-02-22 07:05AM	Century Therapeutics to Host Virtual Research and Development Day on November 11, 2022 (GlobeNewswire)
Oct-05-22 04:05PM	Century Therapeutics to Present at the SITC 37th Annual Meeting (GlobeNewswire)
Oct-03-22 07:00AM	Century Therapeutics Announces Appointment of Daphne Quimi and Timothy Walbert to its Board of Directors (GlobeNewswire)
Sep-26-22 07:00AM	Century Therapeutics to Present at Chardans 6th Annual Genetic Medicines Conference (GlobeNewswire)
Sep-06-22 07:00AM	Century Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-25-22 07:30AM	Century Therapeutics Receives Study May Proceed Notification from FDA for CNTY-101, the First Allogeneic Cell Therapy Product Candidate Engineered to Overcome Three Major Pathways of Host vs Graft Rejection (GlobeNewswire)
Aug-11-22 08:45AM	Century Therapeutics, Inc. (IPSC) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Century Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates (GlobeNewswire)
Jul-07-22 01:43PM	Century Therapeutics nearly tripling planned space at One uCity Square (American City Business Journals)
Jul-01-22 09:18AM	Further weakness as Century Therapeutics (NASDAQ:IPSC) drops 13% this week, taking one-year losses to 71% (Simply Wall St.)
Jun-24-22 04:30PM	Century Therapeutics Announces Its Addition to the Russell Microcap® Index (GlobeNewswire) -6.39% -8.37%
Jun-21-22 04:30PM	Century Therapeutics to Present at the LifeSci Partners 2nd Annual Genetic Medicines Symposium (GlobeNewswire) +5.60%
Jun-06-22 07:30AM	Century Therapeutics to Host Virtual Research and Development Day on June 13, 2022 (GlobeNewswire)
May-20-22 03:04PM	Pennsylvania Biotech Center's economic impact grows to $7B as it expands in Bucks County, report finds (American City Business Journals)
May-16-22 07:30AM	Century Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates (GlobeNewswire) +9.79%
May-03-22 04:30PM	Century Therapeutics to Present at Upcoming Investor Conferences (GlobeNewswire)
May-02-22 04:30PM	Century Therapeutics to Present at the ASGCT 25th Annual Meeting (GlobeNewswire)
Apr-18-22 04:30PM	Century Therapeutics to Present at the Chardan Genetic Medicines and Cell Therapy Manufacturing Summit (GlobeNewswire)
Apr-06-22 04:30PM	Century Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-23-22 04:30PM	Century Therapeutics to Present at the H.C. Wainwright Gene Therapy and Gene Editing Conference (GlobeNewswire) +5.97%
Mar-17-22 07:30AM	Century Therapeutics Reports Fourth Quarter and Year-end 2021 Financial Results and Provides Business Updates (GlobeNewswire)
Feb-09-22 04:05PM	Century Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference (GlobeNewswire)
Jan-22-22 11:29AM	What's Behind Bristol Myers Squibb's Latest Partnership? (Motley Fool)
Jan-14-22 06:50AM	Inside the deal: Why Century Therapeutics picked Bristol Myers Squibb for its first Big Pharma mega-deal (American City Business Journals)
Jan-10-22 12:27PM	Century Therapeutics shares soar on potential multibillion-dollar deal with Bristol Myers Squibb (American City Business Journals) +14.52%
11:12AM	Century Therapeutics Rallies On Bristol Myers Squibb Strategic Collaboration (Investing.com)
08:08AM	Bristol Myers, Century Therapeutics Ink Pact For iPSC-Derived Allogeneic Cell Therapies (Benzinga)
06:59AM	Century Therapeutics and Bristol Myers Squibb Enter into a Strategic Collaboration to Develop iPSC-derived Allogeneic Cell Therapies (GlobeNewswire)
Jan-04-22 04:30PM	Century Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -6.24%
Dec-17-21 07:00AM	Century Therapeutics Added to the NASDAQ Biotechnology Index (GlobeNewswire) +8.91%
Dec-16-21 06:30AM	Century Therapeutics Announces Presentation of Data at the 63rd American Society of Hematology Annual Meeting and Provides Pipeline Updates (GlobeNewswire)
Nov-22-21 08:00AM	Century Therapeutics to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference (GlobeNewswire) -17.56%
Nov-10-21 07:30AM	Century Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates (GlobeNewswire)
Nov-04-21 09:00AM	Century Therapeutics to Present at the 63rd American Society of Hematology Annual Meeting and Host Virtual Research & Development Update (GlobeNewswire)
Oct-07-21 07:30AM	Century Therapeutics and Outpace Bio Enter Research Collaboration in CAR Engineering (GlobeNewswire)

Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi in 2018 and is headquartered in Philadelphia, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Farid Adrienne	Chief Operations Officer	Nov 04 '24	Sale	1.23	1,033	1,267	135,130	Nov 05 04:59 PM
Carr Douglas	SVP Finance & Operations	Nov 04 '24	Sale	1.23	283	347	317,147	Nov 05 04:59 PM
Farid Adrienne	Officer	Nov 04 '24	Proposed Sale	1.23	1,033	1,268		Nov 04 03:52 PM
Quimi Daphne	Director	Sep 12 '24	Buy	1.53	5,000	7,657	5,000	Sep 16 04:18 PM
Farid Adrienne	Chief Operations Officer	Aug 05 '24	Sale	1.83	1,073	1,960	136,163	Aug 07 04:06 PM
Carr Douglas	SVP Finance & Operations	Aug 05 '24	Sale	1.83	289	528	334,041	Aug 07 04:06 PM
Farid Adrienne	Officer	Aug 05 '24	Proposed Sale	1.83	1,073	1,960		Aug 05 03:06 PM
Russotti Gregory	See Remarks	Jul 26 '24	Sale	2.50	586	1,465	274,933	Jul 31 09:08 AM
Russotti Gregory	Officer	Jul 26 '24	Proposed Sale	2.50	586	1,465		Jul 26 05:03 PM
Russotti Gregory	See Remarks	Jul 24 '24	Sale	2.52	1,600	4,029	275,519	Jul 25 05:04 PM
Russotti Gregory	See Remarks	Jul 23 '24	Sale	2.50	200	500	277,119	Jul 25 05:04 PM
Russotti Gregory	See Remarks	Jun 20 '24	Sale	2.84	5,000	14,178	277,319	Jun 24 04:49 PM
Russotti Gregory	See Remarks	Jun 05 '24	Sale	3.00	5,000	14,989	282,319	Jun 06 04:53 PM
Russotti Gregory	See Remarks	May 20 '24	Sale	3.00	5,000	14,978	287,319	May 21 04:09 PM
Russotti Gregory	See Remarks	May 06 '24	Sale	3.12	5,000	15,619	292,319	May 07 05:13 PM
Carr Douglas	SVP Finance & Operations	May 03 '24	Sale	3.11	257	798	317,323	May 07 05:13 PM
Farid Adrienne	Chief Operations Officer	May 03 '24	Sale	3.11	913	2,836	137,236	May 07 05:13 PM
Russotti Gregory	See Remarks	Apr 22 '24	Sale	3.10	5,000	15,490	297,319	Apr 24 04:17 PM
Farid Adrienne	Chief Operations Officer	Mar 06 '24	Option Exercise	1.03	30,684	31,605	144,833	Mar 08 06:29 PM
Farid Adrienne	Chief Operations Officer	Mar 07 '24	Option Exercise	1.03	22,831	23,516	136,980	Mar 08 06:29 PM
Farid Adrienne	Chief Operations Officer	Mar 06 '24	Sale	4.96	30,684	152,340	114,149	Mar 08 06:29 PM
Farid Adrienne	Chief Operations Officer	Mar 07 '24	Sale	5.14	22,831	117,342	114,149	Mar 08 06:29 PM
Farid Adrienne	Chief Operations Officer	Feb 16 '24	Option Exercise	1.03	485	500	114,634	Feb 21 04:10 PM
Farid Adrienne	Chief Operations Officer	Feb 16 '24	Sale	4.86	485	2,358	114,149	Feb 21 04:10 PM
Carr Douglas	SVP Finance & Operations	Feb 06 '24	Sale	4.49	557	2,499	303,580	Feb 07 05:21 PM
Carr Douglas	SVP Finance & Operations	Feb 05 '24	Sale	3.84	643	2,470	304,137	Feb 07 05:21 PM
Farid Adrienne	Chief Operations Officer	Feb 06 '24	Sale	4.49	1,784	8,005	114,149	Feb 07 05:21 PM
Farid Adrienne	Chief Operations Officer	Feb 05 '24	Sale	3.84	2,035	7,816	115,933	Feb 07 05:21 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IPSC

Century Therapeutics Inc

Upgrade your FINVIZ experience